{"title":"Diagnostic Significance of Cell Clusters in Voided Urine in SurePath and ThinPrep Liquid-Based Cytology.","authors":"Yumiko Higuchi, Toshihiko Kato, Mei Oshima, Fuki Endo, Tomonari Toyama, Shiro Sugihara, Sotaro Kayano, Yasuo Imai","doi":"10.1159/acy/abjag005","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diagnostic significance of cell clusters (CCs) appearing in voided urine cytology remains unclear. Epithelial malignancy tends to form large clusters, but tumor cells get discohesive and clusters become smaller with disease progression. We investigated the diagnostic significance of CCs in the differentiation between low-grade urothelial carcinoma (LGUC) and high-grade urothelial carcinoma (HGUC) and then HGUC detection.</p><p><strong>Methods: </strong>In this study, voided urine samples, suspected of new-onset bladder cancer, with corresponding pathological diagnosis were analyzed. Malignancy other than urothelial carcinoma was excluded. Specimens prepared by the SurePath and ThinPrep liquid-based cytology methods were analyzed separately. Cytological diagnosis was based on The Paris System 2.0, and maximal CC size was measured. These data were subject to statistical analysis.</p><p><strong>Results: </strong>123 SurePath and 168 ThinPrep cases were analyzed in this study. Cytological diagnosis was significantly associated with pathological diagnosis in both SurePath and ThinPrep specimens. Then, CC was found to be present in approximately 60% of specimens prepared by both methods. There was no significant difference in CC size among benign lesions, LGUC, and HGUC in both SurePath and ThinPrep specimens. Meanwhile, high-risk cytology which consists of suspicious for HGUC and HGUC based on TPS 2.0 demonstrated similarly high specificity and positive-predictive value for HGUC detection irrespective of CC presence/absence, but sensitivity was significantly higher when CC was present in both SurePath and ThinPrep specimens.</p><p><strong>Conclusion: </strong>Size of CC was not useful for differentiating LGUC from HGUC, but CC presence was advantageous for detecting HGUC possibly due to a sufficient amount of collected cells for diagnosis.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Cytologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/acy/abjag005","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Diagnostic significance of cell clusters (CCs) appearing in voided urine cytology remains unclear. Epithelial malignancy tends to form large clusters, but tumor cells get discohesive and clusters become smaller with disease progression. We investigated the diagnostic significance of CCs in the differentiation between low-grade urothelial carcinoma (LGUC) and high-grade urothelial carcinoma (HGUC) and then HGUC detection.
Methods: In this study, voided urine samples, suspected of new-onset bladder cancer, with corresponding pathological diagnosis were analyzed. Malignancy other than urothelial carcinoma was excluded. Specimens prepared by the SurePath and ThinPrep liquid-based cytology methods were analyzed separately. Cytological diagnosis was based on The Paris System 2.0, and maximal CC size was measured. These data were subject to statistical analysis.
Results: 123 SurePath and 168 ThinPrep cases were analyzed in this study. Cytological diagnosis was significantly associated with pathological diagnosis in both SurePath and ThinPrep specimens. Then, CC was found to be present in approximately 60% of specimens prepared by both methods. There was no significant difference in CC size among benign lesions, LGUC, and HGUC in both SurePath and ThinPrep specimens. Meanwhile, high-risk cytology which consists of suspicious for HGUC and HGUC based on TPS 2.0 demonstrated similarly high specificity and positive-predictive value for HGUC detection irrespective of CC presence/absence, but sensitivity was significantly higher when CC was present in both SurePath and ThinPrep specimens.
Conclusion: Size of CC was not useful for differentiating LGUC from HGUC, but CC presence was advantageous for detecting HGUC possibly due to a sufficient amount of collected cells for diagnosis.
背景:空尿细胞学检查中出现的细胞团(CCs)的诊断意义尚不清楚。上皮恶性肿瘤倾向于形成大的簇状肿瘤,但随着疾病的进展,肿瘤细胞变得不粘连,簇状肿瘤变小。探讨CC在鉴别低级别尿路上皮癌(LGUC)和高级别尿路上皮癌(HGUC)及HGUC检测中的诊断意义。方法:对疑似新发膀胱癌的空尿标本进行病理诊断分析。排除除尿路上皮癌以外的恶性肿瘤。分别对SurePath和ThinPrep液基细胞学方法制备的标本进行分析。细胞学诊断基于Paris系统2.0,并测量最大CC大小。这些数据需要进行统计分析。结果:分析了123例SurePath和168例ThinPrep。在SurePath和ThinPrep标本中,细胞学诊断与病理诊断显著相关。然后,发现CC存在于两种方法制备的约60%的标本中。在SurePath和ThinPrep样本中,良性病变、LGUC和HGUC的CC大小没有显著差异。同时,基于TPS 2.0的HGUC高风险细胞学(包括Suspicious for HGUC和HGUC)无论是否存在CC,对HGUC的检测都具有同样高的特异性和阳性预测值,但当SurePath和ThinPrep标本中同时存在CC时,敏感性明显更高。结论:CC的大小对LGUC和HGUC的区分没有帮助,但CC的存在有利于HGUC的检测,可能是由于收集的细胞数量足够诊断。
期刊介绍:
With articles offering an excellent balance between clinical cytology and cytopathology, ''Acta Cytologica'' fosters the understanding of the pathogenetic mechanisms behind cytomorphology and thus facilitates the translation of frontline research into clinical practice. As the official journal of the International Academy of Cytology and affiliated to over 50 national cytology societies around the world, ''Acta Cytologica'' evaluates new and existing diagnostic applications of scientific advances as well as their clinical correlations. Original papers, review articles, meta-analyses, novel insights from clinical practice, and letters to the editor cover topics from diagnostic cytopathology, gynecologic and non-gynecologic cytopathology to fine needle aspiration, molecular techniques and their diagnostic applications. As the perfect reference for practical use, ''Acta Cytologica'' addresses a multidisciplinary audience practicing clinical cytopathology, cell biology, oncology, interventional radiology, otorhinolaryngology, gastroenterology, urology, pulmonology and preventive medicine.